| Carol M. Moore |
Carol M. Moore is currently working as the Senior VP-Regulatory Affairs, Quality & Clinical at Cerus Corp. She started this position in 2013. Prior to her current role, she worked as the Vice President-Worldwide Regulatory Affairs at Bayer Corp. Ms. Moore holds an MBA from New York University and an undergraduate degree from The Cooper Union School of Engineering. |
| Vivek K. Jayaraman |
Vivek K. Jayaraman is currently the Chief Operating Officer at Cerus Corp. He previously worked as the Vice President-Global Marketing at Medtronic, Inc. and as the Vice President-Global Sales & Marketing at TriVascular, Inc. From 2014 to 2016, he served as the Head-Media Relations and VP-Global Sales & Marketing at Trivascular Technologies, Inc. He also held the position of Vice President-Commercial Operations at Trivascular2, Inc. from 2009 to 2011. Mr. Jayaraman completed his undergraduate degree at the University of Michigan and obtained an MBA from The Wharton School of the University of Pennsylvania. |
| Suzanne Margerum |
Suzanne Margerum is currently the Vice President-Development & Manufacturing at Cerus Corp. She previously worked as the Senior Corporate Counsel at Zynga, Inc. from 2000 to 2011. She received her undergraduate degree from The University of Chicago and the University of Colorado Boulder. |
| Daniel N. Swisher |
Daniel N. Swisher is currently the Chief Executive Officer at NodThera Ltd. since 2024. He is also the Chairman at Cerus Corp. since 2011, an Independent Director at Corcept Therapeutics, Inc. since 2015, and a Director at Protagonist Therapeutics, Inc. since 2023. Previously, Mr. Swisher served as the President, CEO, Secretary & Director at Sunesis Pharmaceuticals, Inc. from 2001 to 2017. He was also the Senior Vice President-Sales & Marketing at ALZA Corp. from 1992 to 2001. Additionally, he held the position of President & Chief Operating Officer at Jazz Pharmaceuticals, Inc. and later became the President at Jazz Pharmaceuticals Plc from 2018 to 2023. Mr. Swisher completed his undergraduate studies at Yale University. He also earned an MBA from Stanford Graduate School of Business in 1991. |
| Chrystal N. Menard |
Chrystal N. Menard is currently the Chief Legal Officer & General Counsel at Cerus Corp. She previously worked as a Partner at Cooley LLP from 2000 to 2011. She also served as a Senior Corporate Counsel at Zynga, Inc. Ms. Menard holds a graduate degree from The University of Chicago and an undergraduate degree from The University of Colorado. |
| Alicia Goodman |
Alicia Goodman is currently the Chief Human Resources Officer at Cerus Corp. Prior to this, she was the Senior Vice President of Human Resources at Aimmune Therapeutics, Inc. from 2019 to 2023. She also served as the Vice President of Human Resources at Novartis AG and the Senior VP, Chief People & Culture Officer at Berg LLC. Ms. Goodman received her undergraduate degree from Michigan State University and her graduate degree from Central Michigan University. |
| Laurence M. Corash |
Laurence M. Corash is the founder of Cerus Corp., a company founded in 1991, where he holds the title of Chief Scientific Officer. He is currently working at The University of California, San Francisco as a Professor since 1982. |
| Richard J. Benjamin |
Richard J. Benjamin is currently the Director & Director-North America Region at the International Society Blood Transfusion, Chief Medical Officer at Cerus Corp., and a Member of the American Association of Blood Banks. Previously, he was the Director at Point Therapeutics, Inc. from 2004 to 2008, Director at DARA BioSciences, Inc. in 2008, Medical Director-Adult Transfusion Service at Harvard University, and Chief Medical Officer at American Red Cross, Inc. He holds a doctorate degree from the University of Cambridge. |
| Kevin Dennis Green |
Kevin Dennis Green is currently the Chief Financial Officer & Vice President-Finance at Cerus Corp. He previously worked as the Finance Director & Assistant Controller at Macromedia, Inc. from 2000 to 2006. Before that, he was a Member at PricewaterhouseCoopers LLP. Mr. Green obtained his undergraduate degree from California State University-Fresno. |
| William Mariner Greenman |
Mr. William M. Greenman is a President, Chief Executive Officer & Director at Cerus Corp. He is on the Board of Directors at Cerus Corp. Mr. Greenman was previously employed as an Independent Director by Aduro BioTech, Inc., an Independent Director by Chinook Therapeutics, Inc., and a Senior Vice President-Biotech Division by Baxter International, Inc. He received his undergraduate degree from Stanford University. |
| Ann Lucena |
Ms. Ann Lucena is an Independent Director at Cerus Corp. and a Chief Executive Officer at San Ramon Regional Medical Center LLC. She is on the Board of Directors at Cerus Corp. and HBS Alumni Angels Association. Ms. Lucena was previously employed as a President-Hospital Operations by Tenet Healthcare Corp. She received her undergraduate degree from Stanford University and an MBA from Harvard Business School. |
| Jami K. Dover Nachtsheim |
Ms. Jami K. Nachtsheim is an Independent Director at Telesis Bio, Inc., an Independent Director at Cerus Corp. and an Independent Director at Intuitive Surgical, Inc. She is on the Board of Directors at Telesis Bio, Inc., Cerus Corp., Intuitive Surgical, Inc. and The Tech Interactive. Ms. Nachtsheim was previously employed as a Chairman by Affymetrix, Inc. and a Vice President-Sales & Marketing Group by Intel Corp. She also served on the board at FEI Co., ACT Conferencing, Inc., Southwall Technologies, Inc., Vixel Corp. and Worldwide Marketing, Inc. She received her undergraduate degree from Arizona State University. |
| Gail Gaumer Schulze |
Ms. Gail G. Schulze is an Independent Director at Cerus Corp. She is on the Board of Directors at Cerus Corp. Ms. Schulze was previously employed as a Chairman by Zosano Pharma, Inc., a Chief Executive Officer & Director by YM Biosciences USA, Inc., a President by YM BioSciences, Inc., a COO & Deputy Chief Executive Officer by Aventis Behring, a Vice President by Allegiance Healthcare Corp., a President-Renal Division Europe by Baxter Healthcare Corp., and a President, Chief Executive Officer & Director by Eximias Pharmaceutical Corp. She received her undergraduate degree from the University of California, Santa Cruz and an MBA from Stanford Graduate School of Business. |
| Timothy L. Moore |
Timothy L. Moore is currently serving as an Independent Director at BioLife Solutions, Inc. and Cerus Corp. He is also a Member of the International Society for Pharmaceutical Engineering and the Parenteral Drug Association. In 2023, he will assume the role of Chief Technical Officer & Executive Vice President at Allogene Therapeutics, Inc. Previously, Mr. Moore held positions as an Independent Non-Executive Director at Cognate BioServices, Inc. and as a Director at Fusionkite. He also served as the Senior Vice President-Global Supply Chain at Genentech, Inc. from 2004 to 2010. Prior to that, he was the Vice President-Operations at Aventis Behring from 2000 to 2004 and held the same position at CSL Behring LLC. From 2016 to 2019, he served as the Executive Vice President-Technical Operations at Kite Pharma, Inc. and as the President, Chief Operating & Technical Officer at PACT Pharma, Inc. Mr. Moore's education includes a graduate degree from Northwestern University and an undergraduate degree from The University of Tulsa. |
| Eric Hands Claude Bjerkholt |
Mr. Eric H. Bjerkholt is a Chief Financial Officer at Mirum Pharmaceuticals, Inc., an Independent Director at Surrozen, Inc., an Independent Director at CalciMedica, Inc. and an Independent Director at Cerus Corp. He is on the Board of Directors at Surrozen, Inc., CalciMedica, Inc., Cerus Corp. and Aimmune Therapeutics UK Ltd. Mr. Bjerkholt was previously employed as a Chief Financial Officer by Chinook Therapeutics, Inc., an Independent Director by Graybug Vision, Inc., a Chief Financial Officer by Aimmune Therapeutics, Inc., an Independent Director by Ambrx, Inc., an Independent Director by StemCells, Inc., a CFO, Secretary & EVP-Corporate Development by Sunesis Pharmaceuticals, Inc., a Chief Financial Officer & Senior Vice President by IntraBiotics Pharmaceuticals, Inc., a President, Chief Executive & Financial Officer by LifeSpring Home Nutrition, a President, Chief Executive & Financial Officer by Kenady LLC, and a Vice President by J.P. Morgan & Co., Inc. (Delaware). He also served on the board at Corium International, Inc., Atara Biotherapeutics, Inc., Round Table Pizza, Inc. and Structure Therapeutics, Inc. He received his undergraduate degree from the University of Oslo and an MBA from Harvard Business School. |
| Franklin R. Witney |
Franklin R. Witney is currently the Chairman at Gyros AB, Gyros Protein Technologies AB, Canopy Biosciences LLC, Jumpcode Genomics, Inc., Telesis Bio, Inc., Cerus Corp., Revvity, Inc., Standard BioTools, Inc., Genoptix, Inc., One Lambda, Inc., Revvity BV, Nexcelom Bioscience LLC, RareCyte, Inc., Emulate, Inc., and Leinco Technologies, Inc. He previously held positions as the President, Chief Executive Officer & Director at Dionex Corp. from 2009 to 2011, President, Chief Executive Officer & Director at Affymetrix, Inc. from 2011 to 2016, President & Chief Executive Officer at Panomics LLC from 2002 to 2008, and Operations Manager-Life Science Group at Bio-Rad Laboratories, Inc. from 1983 to 2000. Dr. Witney also served as the Chief Commercial Officer & Executive VP at Affymetrix, Inc. from 2008 to 2009 and President & Chief Operating Officer at Packard BioScience Co. from 2000 to 2001. He has a doctorate degree from Indiana University and an undergraduate degree from the University of Illinois. |
| Hua Shan |
Dr. Hua Shan is an Independent Director at Cerus Corp. and a Medical Director-Transfusion Medicine Service at Stanford University Medical Center. He is on the Board of Directors at Cerus Corp. |
